Literature DB >> 6368378

Male-specific transplantation antigen expression by XY teratocarcinomas PCC7 and 7'.

L L Johnson, W F Dove.   

Abstract

Male-specific antigen expression by XY teratocarcinomas PCC7 and 7' is demonstrated first by the rejection of tumors by female but not by male mice following challenge with these cell lines. Male-specific antigen expression is confirmed by an indirect method in which females are immunized against H-Y antigen by male skin grafts. A variant of PCC7 lacking male-specific antigen expression is described. Analysis of the karyotype and of the DNA from this variant indicate that the loss of male-specific antigen expression is a result of the loss of the Y chromosome. The ability to recover variants that have lost expression of male-specific antigen opens the possibility of their selection after mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368378     DOI: 10.1007/bf00364766

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

1.  Skin.

Authors:  E J Eichwald; C R Silmser
Journal:  Transplant Bull       Date:  1955

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Serological demonstration of H-Y (male) antigen on mouse sperm.

Authors:  E H Goldberg; E A Boyse; D Bennett; M Scheid; E A Carswell
Journal:  Nature       Date:  1971-08-13       Impact factor: 49.962

4.  Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells.

Authors:  D Morello; F Daniel; P Baldacci; Y Cayre; G Gachelin; P Kourilsky
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

5.  H-Y antigen, serologically detectable male antigen and sex determination.

Authors:  W K Silvers; D L Gasser; E M Eicher
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

6.  Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC.

Authors:  P Stern; M Gidlund; A Orn; H Wigzell
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

7.  Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.

Authors:  A Shedlovsky; L J Clipson; J L VandeBerg; W F Dove
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

8.  The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.

Authors:  P R Avner; W F Dove; P Dubois; J A Gaillard; J L Guénet; F Jacob; H Jakob; A Shedlovsky
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

9.  Assignment of genes to regions of mouse chromosomes.

Authors:  E M Eicher; L L Washburn
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

10.  Association of the H-Y male antigen with beta2-microglobulin on human lymphoid and differentiated mouse teratocarcinoma cell lines.

Authors:  M Fellous; E Günther; R Kemler; J Wiels; R Berger; J L Guenet; H Jakob; F Jacob
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  2 in total

1.  MHC-unrestricted T-cell cytotoxicity against tumour cells.

Authors:  A M Sponaas; B Loveland; E Simpson
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

2.  Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.

Authors:  A R Moser; L L Johnson; W F Dove
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.